Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 12 June 1981:
Vol. 212. no. 4500, pp. 1270 - 1272
DOI: 10.1126/science.7015512

Articles

Science, Vol 212, Issue 4500, 1270-1272
Copyright © 1981 by American Association for the Advancement of Science


articles

Prostacyclin: a potent antimetastatic agent

KV Honn, B Cicone, and A Skoff

Metastasis is the principal cause of failures to cure human cancers. Prostacyclin is a powerful antimetastatic agent against B16 amelanotic melanoma cells. This effect, which may result from the platelet antiaggregatory action of prostacyclin, is potentiated by a phosphodiesterase inhibitor. Inhibitors of prostacyclin synthesis increase metastasis. Prostacyclin and agents that may increase endogenous prostacyclin production or prolong its activity are suggested as new antimetastatic agents.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator-Activated Receptor {gamma}.
R. Nemenoff, A. M. Meyer, T. M. Hudish, A. B. Mozer, A. Snee, S. Narumiya, R. S. Stearman, R. A. Winn, M. Weiser-Evans, M. W. Geraci, et al. (2008)
Cancer Prevention Research 1, 349-356
   Abstract »    Full Text »    PDF »
Did Targeted Therapy Fail Cyclooxygenase Too?.
I. Csiki and D. H. Johnson (2006)
J. Clin. Oncol. 24, 4798-4800
   Full Text »    PDF »
Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps..
E. M. Poole, J. Bigler, J. Whitton, J. G. Sibert, J. D. Potter, and C. M. Ulrich (2006)
Cancer Epidemiol. Biomarkers Prev. 15, 502-508
   Abstract »    Full Text »    PDF »
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.
J. S. Palumbo, K. E. Talmage, J. V. Massari, C. M. La Jeunesse, M. J. Flick, K. W. Kombrinck, M. Jirouskova, and J. L. Degen (2005)
Blood 105, 178-185
   Abstract »    Full Text »    PDF »
Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice.
R. L. Keith, Y. E. Miller, T. M. Hudish, C. E. Girod, S. Sotto-Santiago, W. A. Franklin, R. A. Nemenoff, T. H. March, S. P. Nana-Sinkam, and M. W. Geraci (2004)
Cancer Res. 64, 5897-5904
   Abstract »    Full Text »    PDF »
Manipulation of Pulmonary Prostacyclin Synthase Expression Prevents Murine Lung Cancer.
R. L. Keith, Y. E. Miller, Y. Hoshikawa, M. D. Moore, T. L. Gesell, B. Gao, A. M. Malkinson, H. A. Golpon, R. A. Nemenoff, and M. W. Geraci (2002)
Cancer Res. 62, 734-740
   Abstract »    Full Text »    PDF »
Matrix Metalloproteinase 2 in Tumor Cell-induced Platelet Aggregation: Regulation by Nitric Oxide.
P. Jurasz, G. Sawicki, M. Duszyk, J. Sawicka, C. Miranda, I. Mayers, and M. W. Radomski (2001)
Cancer Res. 61, 376-382
   Abstract »    Full Text »
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.
J. S. Palumbo, K. W. Kombrinck, A. F. Drew, T. S. Grimes, J. H. Kiser, J. L. Degen, and T. H. Bugge (2000)
Blood 96, 3302-3309
   Abstract »    Full Text »    PDF »
Inhibition of Metastases by Anticoagulants.
M. Hejna, M. Raderer, and C. C. Zielinski (1999)
J Natl Cancer Inst 91, 22-36
   Abstract »    Full Text »    PDF »
Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends on Cyclooxygenase-2 Expression and Prostaglandin I Synthase Activity.
M. Camacho, J. Lopez-Belmonte, and L. Vila (1998)
Circ. Res. 83, 353-365
   Abstract »    Full Text »    PDF »
Regulation of PG Synthase by EGF and PDGF in Human Oral, Breast, Stomach, and Fibrosarcoma Cancer Cell Lines.
C.Y. Yang and C.L. Meng (1994)
Journal of Dental Research 73, 1407-1415
   Abstract »    PDF »
Administration of Low-Dose Estrogen Rapidly and Directly Stimulates Growth Hormone Production.
G. Wm. Moll Jr, R. L. Rosenfield, and V. S. Fang (1986)
Arch Pediatr Adolesc Med 140, 124-127
   Abstract »    PDF »
Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.
K. Honn, P Cavanaugh, C Evens, J. Taylor, and B. Sloane (1982)
Science 217, 540-542
   Abstract »    PDF »
Role of Platelets in Tumor Cell Metastases.
S. KARPATKIN and E. PEARLSTEIN (1981)
Ann Intern Med 95, 636-641
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)